This study is to our knowledge the first to demonstrate the tumor-suppressive role of human RNASET2 in prostate cancer, acting through both cell-autonomous mechanisms and non-cell-autonomous pathways, particularly by promoting M1-like macrophage polarization. Here, RNASET2 is linked to prostate cancer.